MIST
Milestone Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$189.44M
P/E Ratio
—
EPS
$-0.75
Beta
0.69
52W High
$3.06
52W Low
$0.69
50-Day MA
$1.65
200-Day MA
$1.88
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Milestone Pharmaceuticals Inc
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular drugs. The company is headquartered in Montral, Canada.
Fundamentals
| Revenue (TTM) | $1.55M |
| Gross Profit (TTM) | $1.55M |
| EBITDA | $-62.03M |
| Operating Margin | -1116.00% |
| Return on Equity | -229.60% |
| Return on Assets | -41.10% |
| Revenue/Share (TTM) | $0.02 |
| Book Value | $0.34 |
| Price-to-Book | 3.92 |
| Price-to-Sales (TTM) | 122.54 |
| EV/Revenue | 75.02 |
| EV/EBITDA | -1.43 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $117.67M |
| Float | $14.06M |
| % Insiders | 2.40% |
| % Institutions | 27.09% |
Analyst Ratings
Consensus ($6.60 target)
1
Strong Buy3
Buy1
HoldData last updated: 4/8/2026